Lingfang Xia

1PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Dec 09, 2022
A multicenter phase 2 trial of camrelizumab plus famitinib for women with recurrent or metastatic cervical squamous cell carcinoma.

Lingfang Xia, Qi Zhou, Yunong Gao

Pageof 1

Frequent Collaborators

1 joint publications

Qi Zhou

1 joint publications

Yunong Gao

1 joint publications

Ge Lou

1 joint publications

Hong Sun